These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16421631)

  • 1. Molecule of the month. Rotigaptide.
    Drug News Perspect; 2005 Nov; 18(9):585-6. PubMed ID: 16421631
    [No Abstract]   [Full Text] [Related]  

  • 2. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotigaptide (ZP123) reverts established atrial conduction velocity slowing.
    Haugan K; Kjølbye AL; Hennan JK; Petersen JS
    Cell Commun Adhes; 2005; 12(5-6):271-8. PubMed ID: 16531322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria.
    Haugan K; Miyamoto T; Takeishi Y; Kubota I; Nakayama J; Shimojo H; Hirose M
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):71-9. PubMed ID: 16867174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.
    Kjølbye AL; Haugan K; Hennan JK; Petersen JS
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):215-30. PubMed ID: 17845503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts.
    Hsieh YC; Lin JC; Hung CY; Li CH; Lin SF; Yeh HI; Huang JL; Lo CP; Haugan K; Larsen BD; Wu TJ
    Heart Rhythm; 2016 Jan; 13(1):251-61. PubMed ID: 26188250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans.
    Kjølbye AL; Dikshteyn M; Eloff BC; Deschênes I; Rosenbaum DS
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H41-9. PubMed ID: 17982010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure.
    Wiegerinck RF; de Bakker JM; Opthof T; de Jonge N; Kirkels H; Wilms-Schopman FJ; Coronel R
    Basic Res Cardiol; 2009 May; 104(3):321-32. PubMed ID: 19139945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction.
    Haugan K; Marcussen N; Kjølbye AL; Nielsen MS; Hennan JK; Petersen JS
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):236-42. PubMed ID: 16495761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development for treatment of cardiac arrhythmias: targeting the gap junctions.
    Wit AL; Duffy HS
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H16-8. PubMed ID: 17890421
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of ventricular gap-junction coupling by rotigaptide.
    Lin X; Zemlin C; Hennan JK; Petersen JS; Veenstra RD
    Cardiovasc Res; 2008 Aug; 79(3):416-26. PubMed ID: 18430749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation.
    Butera JA; Larsen BD; Hennan JK; Kerns E; Di L; Alimardanov A; Swillo RE; Morgan GA; Liu K; Wang Q; Rossman EI; Unwalla R; McDonald L; Huselton C; Petersen JS
    J Med Chem; 2009 Feb; 52(4):908-11. PubMed ID: 19175320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiarrhythmic peptide rotigaptide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes.
    Stahlhut M; Petersen JS; Hennan JK; Ramirez MT
    Cell Commun Adhes; 2006; 13(1-2):21-7. PubMed ID: 16613777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative druggable targets for selective enhancement of cardiac conduction.
    Gomes J; Lambiase PD
    Curr Opin Pharmacol; 2009 Apr; 9(2):154-9. PubMed ID: 19109070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the anti-arrhythmic activity of serpentine and its effect on the heart conduction system].
    Gendenshteĭn EI; Mikhaĭlenko LA
    Farmakol Toksikol; 1965; 28(1):42-6. PubMed ID: 5845040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of cellular action of anti-arrhythmia agents].
    Sebag C; Motté G
    Coeur Med Interne; 1978; 17(4):508-19. PubMed ID: 737994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiarrhythmic agents and atrioventricular conduction].
    Knippel M; Rovelli F
    G Ital Cardiol; 1972; 2(1):184. PubMed ID: 5012012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter: Cardiac automatism].
    Porciello PI; Domenichelli B
    G Ital Cardiol; 1973; 3(3):452-6. PubMed ID: 4766980
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of rotigaptide, a gap junction modifier, on defibrillation energy and resuscitation from cardiac arrest in rabbits.
    Zhong JQ; Laurent G; So PP; Hu X; Hennan JK; Dorian P
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):69-77. PubMed ID: 17495260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.